HT Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $509K | Hold |
2,741
| – | – | 0.16% | 32 |
|
2025
Q1 | $574K | Hold |
2,741
| – | – | 0.2% | 30 |
|
2024
Q4 | $487K | Hold |
2,741
| – | – | 0.17% | 31 |
|
2024
Q3 | $541K | Hold |
2,741
| – | – | 0.19% | 29 |
|
2024
Q2 | $470K | Hold |
2,741
| – | – | 0.17% | 30 |
|
2024
Q1 | $499K | Sell |
2,741
-135
| -5% | -$24.6K | 0.18% | 29 |
|
2023
Q4 | $446K | Hold |
2,876
| – | – | 0.18% | 28 |
|
2023
Q3 | $429K | Hold |
2,876
| – | – | 0.13% | 30 |
|
2023
Q2 | $387K | Sell |
2,876
-60
| -2% | -$8.08K | 0.11% | 34 |
|
2023
Q1 | $468K | Buy |
2,936
+195
| +7% | +$31.1K | 0.14% | 30 |
|
2022
Q4 | $443K | Hold |
2,741
| – | – | 0.15% | 26 |
|
2022
Q3 | $368K | Hold |
2,741
| – | – | 0.16% | 29 |
|
2022
Q2 | $420K | Hold |
2,741
| – | – | 0.17% | 30 |
|
2022
Q1 | $444K | Hold |
2,741
| – | – | 0.14% | 31 |
|
2021
Q4 | $371K | Hold |
2,741
| – | – | 0.11% | 36 |
|
2021
Q3 | $296K | Hold |
2,741
| – | – | 0.09% | 39 |
|
2021
Q2 | $309K | Hold |
2,741
| – | – | 0.09% | 36 |
|
2021
Q1 | $297K | Hold |
2,741
| – | – | 0.1% | 37 |
|
2020
Q4 | $294K | Buy |
+2,741
| New | +$294K | 0.1% | 36 |
|